Alpha 2.0
Login Register
» Authors » Adrianna Westbrook

Adrianna Westbrook

Explore the profile of Adrianna Westbrook including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 49
Followers 0
Related Specialties
Pediatrics
General Medicine
Public Health
Top 10 Co-Authors
Wilbur A Lam
Muna Qayed
Changwei Li
Morgan Greenleaf
Anuradha Rao
Leda Bassit
Julie A Sullivan
John D Roback
Ruiyuan Zhang
Chris A Rees
Published In
medRxiv
PLoS One
BMJ Paediatr Open
Epidemiol Infect
Obesity (Silver Spring)
Affiliations
Soon will be listed here.
Recent Articles
1.
Incidence of Leading Causes of Pediatric Chronic Kidney Disease Using Electronic Health Record-Driven Computable Phenotype
Beus J, Liu K, Westbrook A, Harding J, Orenstein E, Shin H, et al.
Kidney360 . 2025 Mar; PMID: 40036078
Background: Incidence data on pediatric chronic kidney disease (CKD) is incomplete. We developed electronic health record (EHR)-based algorithms (e-phenotypes) to identify cases and provide incidence estimates of 5 leading causes...
2.
Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocol
Swenson C, Hunt W, Manfredi C, Beltran D, Hong J, Davis B, et al.
PLoS One . 2025 Feb; 20(2):e0316721. PMID: 39951444
Background: Non-cystic fibrosis bronchiectasis (NCFBE) is a disease that exhibits dilatation of airways, airflow obstruction, persistent cough, excessive sputum production, and refractory respiratory infections. NCFBE exhibits clinical and pathological manifestations...
3.
Development of a multi-year pediatric antibiogram in Georgia identifies antibiotic resistance changes over the past ten years
Linam M, Goldstein M, Huang T, Westbrook A, Jerris R, Gonzalez M
Antimicrob Steward Healthc Epidemiol . 2025 Feb; 5(1):e37. PMID: 39950002
Background: Antibiograms monitor antibiotic resistance trends and help guide empiric antibiotic treatment. A statewide pediatric antibiogram can help inform stewardship efforts. Methods: Annual pediatric antibiograms for the five children's hospitals...
4.
Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children
Schoettler M, Ofori J, Bryson E, Spencer K, Qayed M, Stenger E, et al.
Transplant Cell Ther . 2024 Jun; 30(9):929.e1-929.e6. PMID: 38936547
Consensus diagnostic and risk stratification of transplantation-associated thrombotic microangiopathy (TA-TMA) was recently achieved from international transplantation groups. Although the proposed diagnostic criteria have been applied to multiple pediatric cohorts, there...
5.
Morbidity and unplanned healthcare encounters after hospital discharge among young children in Dar es Salaam, Tanzania and Monrovia, Liberia
Kisenge R, Ideh R, Kamara J, Coleman-Nekar Y, Samma A, Godfrey E, et al.
BMJ Paediatr Open . 2024 Jun; 8(1. PMID: 38906561
Background: Researchers and healthcare providers have paid little attention to morbidity and unplanned healthcare encounters for children following hospital discharge in low- and middle-income countries. Our objective was to compare...
6.
Derivation and Internal Validation of a Novel Risk Assessment Tool to Identify Infants and Young Children at Risk for Post-Discharge Mortality in Dar es Salaam, Tanzania and Monrovia, Liberia
Rees C, Kisenge R, Godfrey E, Ideh R, Kamara J, Coleman-Nekar Y, et al.
J Pediatr . 2024 Jun; 273:114147. PMID: 38878962
Objective: To derive and validate internally a novel risk assessment tool to identify young children at risk for all-cause mortality ≤60 days of discharge from hospitals in sub-Saharan Africa. Study...
7.
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-A secondary CIBMTR analysis
Schoettler M, Westbrook A, Watkins B, Stenger E, Qayed M, Chonat S, et al.
Br J Haematol . 2024 May; 205(1):243-255. PMID: 38817006
Most reports of risk factors (RF) for developing transplant-associated thrombotic microangiopathy (TA-TMA) and death are derived from paediatric and young adult cohorts, with minimal data on differences in RF and...
8.
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
Qayed M, Kapoor U, Gillespie S, Westbrook A, Aguayo-Hiraldo P, Ayuk F, et al.
Transplant Cell Ther . 2024 Mar; 30(6):603.e1-603.e11. PMID: 38548227
Acute graft versus host disease (GVHD) is a common and serious complication of allogeneic hematopoietic cell transplantation (HCT) in children but overall clinical grade at onset only modestly predicts response...
9.
Comparison of RT-PCR and antigen test sensitivity across nasopharyngeal, nares, and oropharyngeal swab, and saliva sample types during the SARS-CoV-2 omicron variant
Damhorst G, Lin J, Frediani J, Sullivan J, Westbrook A, McLendon K, et al.
Heliyon . 2024 Mar; 10(6):e27188. PMID: 38500996
Limited data highlight the need to understand differences in SARS-CoV-2 omicron (B.1.1.529) variant viral load between the gold standard nasopharyngeal (NP) swab, mid-turbinate (MT)/anterior nasal swabs, oropharyngeal (OP) swabs, and...
10.
D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study
Schoettler M, French K, Harris A, Bryson E, Deeb L, Hudson Z, et al.
Am J Hematol . 2024 Jan; 99(3):370-379. PMID: 38164997
Transplant-associated thrombotic microangiopathy (TA-TMA) is a common, severe complication of allogeneic hematopoietic cellular therapy (HCT). Even when treated in many studies, morbidity and mortality rates are high. This prospective single-institution...